Observational Study on the Prevalence of Urinary Incontinence in Federates Athletes.

April 17, 2020 updated by: JORGE VELAZQUEZ SAORNIL, Universidad Católica de Ávila

Observational Study on the Prevalence of Urinary Incontinence in Federates Athletes in Castilla y León.

To study the prevalence of urinary incontinence (UI) in female athletes from Castilla y León, as well as the category of athletics with the highest number of losses, the most incident risk factors and the bio-psycho-social consequences that it leads to.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Elaboration of a survey, based on two validated questionnaires to which 63 participants have answered, to carry out an analytical, transversal and observational study. All the participants are women, of age, federated in athletics and belonging to Castilla y León.

UI has a high prevalence (44.4%) in female athletes, being more common in those who practice long-distance races. As age and years of sport increase, the incidence of this pathology increases. Absorbent pads are used by more than half of the incontinent women, while the rest wet their underwear. Menopause, childbirth and surgery in the region are risk factors for UTIs, while the presence of urinary tract infections or candidiasis are not. The results affirm that urine leaks do not cause anxiety or depression, but they do affect your sporting life.

Study Type

Observational

Enrollment (Actual)

63

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Avila, Spain, 05005
        • Universidad Católica de Ávila

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

female athletes over 18 and under 65

Description

Inclusion Criteria:

  • Female sex.
  • Adulthood.
  • Federated in athletics.

Exclusion Criteria:

  • Men.
  • Those women who are no longer federated or who are minors.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
female athletes over the age of 18
the presence or absence of urinary incontinence in female athletes is studied. In addition, the quality of life and other aspects are evaluated
Behavioral: female athletes
The type of incontinence is assessed, whether there are risk factors and quality of life and psychological performance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants suffering from urinary incontinence
Time Frame: 2 months
observe whether female athletes suffer from urinary incontinence
2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants suffering from urinary incontinence with a bio-psycho-social component
Time Frame: 2 months
observe the bio-psycho-social component of suffering from urinary incontinence
2 months
Incidence rate and urinary incontinence according to athletic discipline
Time Frame: 2 months
to see if athletic discipline is related to urinary incontinence
2 months
Incidence rate and urinary incontinence and associated risk factors
Time Frame: 2 months
look at the risk factors associated with urinary incontinence
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Católica de Ávila

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2020

Primary Completion (Actual)

March 10, 2020

Study Completion (Actual)

April 1, 2020

Study Registration Dates

First Submitted

April 15, 2020

First Submitted That Met QC Criteria

April 15, 2020

First Posted (Actual)

April 20, 2020

Study Record Updates

Last Update Posted (Actual)

April 21, 2020

Last Update Submitted That Met QC Criteria

April 17, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 003/2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Incontinence

Clinical Trials on female athletes

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe